Bausch + Lomb Announces Participation at Upcoming Investor Conferences

VAUGHAN, ON, Aug. 29, 2022 /CNW/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Wells Fargo 2022 Healthcare Conference in Boston on Sept. 7, 2022 1:55 p.m. ET and at the 20^th Annual Morgan Stanley Global Healthcare Conference in New York on Sept. 13, 2022 at 10:00 a.m. ET.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

SOURCE Bausch + Lomb Corporation